US Stock MarketDetailed Quotes
ZEPP Zepp Health
- 3.140
- +0.390+14.18%
Close Nov 29 13:00 ET
- 3.140
- 0.0000.00%
Post 17:01 ET
45.92MMarket Cap-218P/E (TTM)
3.200High2.728Low6.65KVolume2.730Open2.750Pre Close19.48KTurnover0.10%Turnover RatioLossP/E (Static)14.63MShares8.40052wk High0.15P/B21.67MFloat Cap2.06052wk Low--Dividend TTM6.90MShs Float78.344Historical High--Div YieldTTM17.18%Amplitude2.060Historical Low2.927Avg Price1Lot Size
Zepp Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -48.91%42.46M | -56.04%40.64M | -56.95%40.36M | -41.38%352.02M | -51.52%82.17M | -50.88%83.11M | -44.10%92.45M | -21.27%93.75M | -38.76%600.48M | -37.58%169.5M |
| Operating revenue | -48.91%42.46M | -56.04%40.64M | -56.95%40.36M | -41.38%352.02M | -51.52%82.17M | -50.88%83.11M | -44.10%92.45M | -21.27%93.75M | -38.76%600.48M | -37.58%169.5M |
| Cost of revenue | -54.10%25.22M | -66.33%24.28M | -67.63%25.51M | -46.45%259.23M | -60.72%52.9M | -59.85%54.94M | -46.88%72.12M | -17.16%78.81M | -37.60%484.07M | -38.48%134.67M |
| Gross profit | -38.78%17.24M | -19.50%16.36M | -0.63%14.85M | -20.28%92.79M | -15.98%29.27M | -12.98%28.17M | -31.32%20.33M | -37.59%14.94M | -43.17%116.41M | -33.82%34.84M |
| Operating expense | 11.16%29.78M | -14.61%26.23M | -16.38%30.83M | -30.62%122.01M | -41.28%27.41M | -37.19%26.79M | -33.38%30.71M | -23.81%36.87M | -7.49%175.87M | -8.20%46.68M |
| Selling and administrative expenses | 15.20%18.92M | -14.12%15.41M | -12.26%17.32M | -29.67%70.97M | -40.72%16.75M | -33.71%16.43M | -33.18%17.94M | -22.16%19.74M | -7.66%100.91M | -19.61%28.25M |
| -Selling and marketing expense | 21.94%11.9M | 3.34%10.56M | -13.04%10.86M | -33.49%44.38M | -39.86%11.83M | -43.87%9.76M | -36.77%10.21M | -22.96%12.49M | -2.97%66.72M | -19.81%19.68M |
| -General and administrative expense | 5.35%7.03M | -37.19%4.85M | -10.93%6.46M | -22.23%26.59M | -42.69%4.92M | -9.85%6.67M | -27.77%7.73M | -20.74%7.25M | -15.63%34.2M | -19.16%8.58M |
| Research and development costs | 4.77%10.86M | -15.29%10.82M | -21.13%13.51M | -31.90%51.04M | -42.15%10.66M | -42.02%10.37M | -33.65%12.77M | -25.62%17.13M | -7.25%74.95M | 17.32%18.43M |
| Operating profit | -1,009.14%-12.54M | 5.03%-9.87M | 27.11%-15.98M | 50.86%-29.22M | 115.69%1.86M | 113.41%1.38M | 37.06%-10.39M | 10.31%-21.93M | -503.45%-59.46M | -766.59%-11.85M |
| Net non-operating interest income expense | 56.50%-348K | 53.19%-425K | 67.42%-434.78K | 43.81%-3.64M | 68.28%-587.81K | 51.81%-800K | 49.18%-908K | 6.99%-1.33M | -46.35%-6.47M | -0.15%-1.85M |
| Non-operating interest income | 15.89%941K | 11.79%948K | 70.27%1.02M | 72.95%3.09M | 23.51%827.87K | 77.06%812K | 164.58%848K | 49.91%600.56K | -31.71%1.79M | 39.24%670.26K |
| Non-operating interest expense | -20.04%1.29M | -21.81%1.37M | -24.69%1.46M | -18.55%6.73M | -43.90%1.42M | -23.92%1.61M | -16.67%1.76M | 5.43%1.94M | 17.33%8.26M | 8.22%2.52M |
| Other net income (expense) | 146.43%91K | -140.33%-173K | 996.87%2.19M | -104.60%-549.47K | -189.17%-983.47K | -104.53%-196K | 131.67%429K | -97.71%199.94K | 85.96%11.94M | -70.28%1.1M |
| Gain on sale of security | 306.98%175K | -155.45%-300K | 334.99%2.12M | -96.24%285.81K | -126.47%-789.19K | 104.13%43K | 131.81%541K | -93.99%488.38K | 258.51%7.6M | 9,239.50%2.98M |
| Special income (charges) | ---- | ---- | ---- | 84.11%-319.24K | ---- | ---- | ---- | ---- | ---2.01M | ---- |
| -Write off | ---- | ---- | ---- | -84.11%319.24K | ---- | ---- | ---- | ---- | --2.01M | ---- |
| Other non- operating income (expenses) | 64.85%-84K | 213.39%127K | 123.82%68.72K | -108.12%-516.04K | -3.82%124.96K | -104.45%-239K | -132.35%-112K | -148.97%-288.44K | 47.66%6.35M | -96.47%129.93K |
| Income before tax | -3,440.47%-12.79M | 3.71%-10.46M | 38.32%-14.22M | 38.14%-33.4M | 102.29%288.22K | 105.03%383K | 44.69%-10.87M | -34.38%-23.06M | -422.66%-54M | -446.29%-12.6M |
| Income tax | 0 | 102.84%47K | 102.01%72.23K | 76.62%-2.23M | 553.79%2.97M | 101.40%66K | 14.75%-1.66M | -36.44%-3.59M | -666.41%-9.55M | -731.53%-655.14K |
| Earnings from equity interest net of tax | -811.76%-465K | 60.63%-337K | -32.57%-564.62K | -53.80%1.18M | 13,918.79%2.52M | -110.66%-51K | -150.10%-856K | -177.19%-425.9K | -60.24%2.56M | -100.77%-18.22K |
| Net income | -5,084.59%-13.26M | -7.76%-10.85M | 25.30%-14.86M | 28.41%-29.99M | 98.60%-167.28K | 111.01%266K | 37.06%-10.07M | -42.34%-19.89M | -294.96%-41.89M | -302.44%-11.96M |
| Net income continuous Operations | -5,084.59%-13.26M | -7.76%-10.85M | 25.30%-14.86M | 28.41%-29.99M | 98.60%-167.28K | 111.01%266K | 37.06%-10.07M | -42.34%-19.89M | -294.96%-41.89M | -302.44%-11.96M |
| Minority interest income | 70.37%-8K | 61.54%-10K | -15.15%-32.46K | 34.69%-65.6K | 150.40%15.4K | -51.50%-27K | 26.48%-26K | -33.75%-28.19K | 24.77%-100.44K | -8.06%-30.56K |
| Net income attributable to the parent company | -4,622.53%-13.25M | -7.94%-10.84M | 25.36%-14.83M | 28.39%-29.92M | 98.47%-182.68K | 112.22%293K | 37.08%-10.04M | -42.36%-19.87M | -293.29%-41.79M | -300.96%-11.93M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -4,622.53%-13.25M | -7.94%-10.84M | 25.36%-14.83M | 28.39%-29.92M | 98.47%-182.68K | 112.22%293K | 37.08%-10.04M | -42.36%-19.87M | -293.29%-41.79M | -300.96%-11.93M |
| Basic earnings per share | -5,100.00%-0.8 | 0.00%-0.64 | 29.20%-0.9218 | 27.63%-1.9637 | 90.58%-0.0677 | 110.18%0.016 | 39.07%-0.64 | -43.71%-1.302 | -296.53%-2.7133 | -304.57%-0.7189 |
| Diluted earnings per share | -5,100.00%-0.8 | 0.00%-0.64 | 29.20%-0.9218 | 27.63%-1.9637 | 90.58%-0.0677 | 110.18%0.016 | 39.07%-0.64 | -43.71%-1.302 | -307.87%-2.7133 | -304.57%-0.7189 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
